UAE Business: Arzan Wealth achieves successful exit of US’ Glaukos – Gulf Digital News

0
205

UAE Business: Arzan Wealth achieves successful exit of US’ Glaukos – Gulf Digital News

Arzan Wealth Limited, a Dubai-based advisory firm regulated by the Dubai Financial Services Authority, has advised its client on the sale of the Medical Technology Campus of Glaukos Corporation, US.  Glaukos is located in a highly desirable part of Orange County, California, achieving strong returns for investors. The sold property houses the headquarters offices of Glaukos as well as their primary R&D facilities. The campus consists of three newly refurbished buildings comprising 159,746 sq ft and fully let to Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.  Glaukos was the first company to introduce Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure which revolutionised the treatment and management of glaucoma.   The Property was acquired in June-2020 as part of Arzan Wealth’s yielding asset platform with an objective of producing an average annual yield of 9.15% to investors, and an IRR of around 10.7% over a five-year holding period.  Arzan Wealth advised on the exit of this investment at a price that far exceeded initial expectations, and which reflected the success of Arzan Wealth in acquiring the asset at a good price in the midst